Tenet Declines as 2014 Forecast Fails to Meet Estimates

Tenet Healthcare Corp. (THC), the third-largest U.S. for-profit hospital company, declined the most in three months after providing a 2014 forecast that was lower than analysts’ estimates.

Tenet fell 10 percent to $43.30 at 1:46 p.m. New York time, after earlier declining as much as 11 percent, the biggest intraday drop for the Dallas-based company since Nov. 5.

Earnings before interest, taxes, depreciation and amortization may be $1.8 billion to $1.9 billion this year, the company said yesterday in a statement. Analysts anticipated $1.96 billion, the average of 18 estimates compiled by Bloomberg. The forecast includes expected government reimbursement cuts, Chief Financial Officer Daniel Cancelmi said today on a conference call.

Tenet’s 2014 outlook was cause for “significant concerns,” Sheryl Skolnick, a Stamford, Connecticut-based analyst at CRT Capital Group LLC wrote today in a note to clients. Skolnick, who had estimated 2014 Ebitda of $2.1 billion, lowered her rating to hold from buy.

“The stock is too rich, the promise of reform too thin, and execution too variable for us to continue to rate THC shares a ‘buy,’” she said.

To contact the reporter on this story: Caroline Chen in New York at cchen509@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.